Literature DB >> 15826719

Mild hypothermia prevents brain edema and attenuates up-regulation of the astrocytic benzodiazepine receptor in experimental acute liver failure.

Mireille Bélanger1, Paul Desjardins, Nicolas Chatauret, Christopher Rose, Roger F Butterworth.   

Abstract

BACKGROUND/AIMS: Mild hypothermia has proven useful in the clinical management of patients with acute liver failure. Acute liver failure in experimental animals results in alterations in the expression of genes coding for astrocytic proteins including the "peripheral-type" (astrocytic) benzodiazepine receptor (PTBR), a mitochondrial complex associated with neurosteroid synthesis. To gain further insight into the mechanisms whereby hypothermia attenuates the neurological complications of acute liver failure, we investigated PTBR expression in the brains of hepatic devascularized rats under normothermic (37 degrees C) and hypothermic (35 degrees C) conditions.
METHODS: PTBR mRNA was measured using semi-quantitative RT-PCR in cerebral cortical extracts and densities of PTBR sites were measured by quantitative receptor autoradiagraphy. Brain pregnenolone content was measured by radioimmunoassay.
RESULTS: At coma stages of encephalopathy, animals with acute liver failure manifested a significant increase of PTBR mRNA levels. Brain pregnenolone content and [(3)H]PK 11195 binding site densities were concomitantly increased. Mild hypothermia prevented brain edema and significantly attenuated the increased receptor expression and pregnenolone content.
CONCLUSIONS: These findings suggest that an attenuation of PTBR up-regulation resulting in the prevention of increased brain neurosteroid content represents one of the mechanisms by which mild hypothermia exerts its protective effects in ALF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15826719     DOI: 10.1016/j.jhep.2004.12.029

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  8 in total

Review 1.  Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure.

Authors:  Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2014-07-09

2.  TGR5 signaling reduces neuroinflammation during hepatic encephalopathy.

Authors:  Matthew McMillin; Gabriel Frampton; Richard Tobin; Giuseppina Dusio; Jenny Smith; Hope Shin; Karen Newell-Rogers; Stephanie Grant; Sharon DeMorrow
Journal:  J Neurochem       Date:  2015-09-10       Impact factor: 5.372

Review 3.  Mechanisms, diagnosis and management of hepatic encephalopathy.

Authors:  Ravi Prakash; Kevin D Mullen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-10       Impact factor: 46.802

4.  Hepatic encephalopathy: An approach to its multiple pathophysiological features.

Authors:  Juan Carlos Perazzo; Silvina Tallis; Amalia Delfante; Pablo Andrés Souto; Abraham Lemberg; Francisco Xavier Eizayaga; Salvador Romay
Journal:  World J Hepatol       Date:  2012-03-27

Review 5.  The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy.

Authors:  Samir Ahboucha; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 6.  Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management.

Authors:  Julia Wendon; William Lee
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

7.  Chondroitin Sulfate-Rich Extract of Skate Cartilage Attenuates Lipopolysaccharide-Induced Liver Damage in Mice.

Authors:  Yeong Ok Song; Mijeong Kim; Minji Woo; Jang-Mi Baek; Keon-Hee Kang; Sang-Ho Kim; Seong-Soo Roh; Chan Hum Park; Kap-Seop Jeong; Jeong-Sook Noh
Journal:  Mar Drugs       Date:  2017-06-15       Impact factor: 5.118

8.  Molecular and cellular pathways as a target of therapeutic hypothermia: pharmacological aspect.

Authors:  Hyung Soo Han; Jaechan Park; Jong-Heon Kim; Kyoungho Suk
Journal:  Curr Neuropharmacol       Date:  2012-03       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.